-
OXiGENE Announces Name Change to Mateon Therapeutics
17 Jun 2016 14:15 GMT
… 17, 2016 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a … , 2016. At that time, shares of Mateon’s common stock … in orphan oncology indications.” OXiGENE was named for its founding … when the Company was named OXiGENE, Inc. However, Mateon undertakes …
-
OXiGENE Reports First Quarter 2016 Financial Results
09 May 2016 12:00 GMT
… shareholders.” About OXiGENE OXiGENE is a … ended December 31, 2015.
OXiGENE, Inc.
Balance Sheet Data
… shares
outstanding
26,545
21,095
Investor and Media Contact:
ir@oxigene …
-
OXiGENE Reports 2015 Financial Results
28 Mar 2016 12:30 GMT
… going.” About OXiGENE OXiGENE is a … 30,423
OXiGENE, Inc.
Statement of Operations Data … shares
outstanding
25,201
16,973
Investor and Media Contact:
ir@oxigene …
-
OXiGENE Reports Third Quarter 2015 Financial Results
10 Nov 2015 21:15 GMT
… , 2015 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a … are substantial."
About OXiGENE
OXiGENE is a clinical-stage … 736
$ 30,423
OXiGENE, Inc.
Statement of Operations … Weighted-average number of common shares outstanding
26,545
…
-
Oncotelic Therapeutics, Inc. to Sell Its Necroptosis Cancer Therapy Assets to Mosaic ImmunoEngineering, Inc.
29 Apr 2024 11:00 GMT
… Oncotelic $15 million in CPMV shares upon execution of the definitive … an additional $15 million in shares of CPMV. The Mosaic team … New York in 1988 as OXiGENE, Inc., was reincorporated in the …